Customized approach.

10 March 2017

Digital deals: spotlight on life sciences

Inorganic strategies are driving the digital agenda in life sciences.

1 March 2017

Video: Outlook for the medtech sector

Watch Parthenon-EY Managing Director and Co-head of Health Care Dan Shoenholz and EY Partner Arda Ural discuss growth themes in medtech in 2017.

24 January 2017

If you look at your company the way an activist does, what would you change?

Parthenon-EY’s in-depth research shows where and how companies can harness shareholder activists’ tactics for competitive advantage.

4 January 2017

The new innovation imperative: Reshaping biopharma business models

New technologies, customers and competition are forcing — and enabling — biopharmaceutical companies to find novel ways to create and capture value.

19 December 2016

Breaking down silos to put students on the path to success

Parthenon-EY’s Education practice assesses the potential impact of early college high schools using data and perspectives from Massachusetts and around the country.

5 December 2016

Why due diligence fails

Listen to Jay Bartlett and Scott Orleck on this podcast sharing their experiences and takeaways from buy-side due diligence projects.

About us

The Parthenon-EY team is committed to bringing unconventional yet pragmatic thinking together with our clients’ smarts to deliver actionable strategies for real impact in today’s complex business landscape.

Featured events

Our people